A new analysis from Avalere finds that Medicare patients’ out-of-pocket costs for new cancer therapies can vary substantially based on whether a drug is covered by Part B or Part D, due to differing benefit designs and the use of [...]
The pharmacist is ready to shout out the names of his customers before they walk through the door of his spotless and brightly lit pharmacy. Typically, their medication is on the counter before they make their way to the register. [...]
Some contend that the federal government should negotiate drug prices directly to achieve lower prices for consumers, but this proposal has numerous flaws. Read the full article on American Action Forum here.
The Trump administration's "Blueprint" to lower drug prices and reduce patient costs made one thing clear: The government will not directly negotiate with drug companies to secure lower prescription prices. But that doesn't mean it isn't proposing changes that would dramatically [...]
In an effort to reduce improper payments and reduce expenses, the Medicare program has experimented with requiring prior authorization. This means beneficiaries need approval before they can receive certain services or items like powered wheelchairs. Read the full article on [...]
The maligned and ardently defended 340B drug pricing program allows qualifying hospitals and clinics (those serving a disproportionate share of low-income patients or receiving federal grants to provide specific services) to generate revenue by purchasing prescription drugs from pharmaceutical manufacturers [...]
Drugs administered by doctors, such as infusion treatments for cancer or autoimmune diseases, may soon be sold through prescriptions under President Donald Trump’s plan to rein in spiraling drug prices. Read the full article on Bloomberg here.
The East Side pharmacist is ready to shout out the names of his customers before they walk through the door of his spotless and brightly lit pharmacy. Typically, the medication is on the counter before the customers make their way [...]
Randy Mansfield knows what it’s like to face cancer. Now he’s committed to help get affordable cancer care in a local or community setting. As part of the Community Oncology Alliance (COA), Mansfield recently went back to Washington, D.C. to [...]
Doctors should get out of the business of making money off of providing prescription drugs to Medicare beneficiaries, Health and Human Services Secretary Alex Azar said Monday. Read the full article on MedPage Today here.